Randomised Controlled TrialtaVNS

Meniere Disease treated with transcutaneous auricular vagus nerve stimulation combined with betahistine Mesylate: A randomized controlled trial

Wu D, Liu B, Wu Y, Wang Y, Sun J, Yang J, Duan J, Liu G, Cao K, Zhang Y, et al.

Brain Stimulation · 2023

Key finding

In an RCT, taVNS added to betahistine significantly reduced tinnitus and dizziness handicap, aural fullness and hearing thresholds in Meniere's disease.

Auto-extracted · verification pendingHow we verify

Condition
Tinnitus
Stimulation
taVNS
Evidence tier
Randomised Controlled Trial
Participants
View on DOI

Share this study

Download the citation card as a PNG, or copy a link to this page.

Cite this study

Wu, D., Liu, B., Wu, Y., Wang, Y., Sun, J., Yang, J., Duan, J., Liu, G., Cao, K., Zhang, Y., & Rong, P. (2023). Meniere Disease treated with transcutaneous auricular vagus nerve stimulation combined with betahistine Mesylate: A randomized controlled trial. Brain Stimulation, 16(6), 1576-1584. https://doi.org/10.1016/j.brs.2023.10.003

Related studies in Tinnitus

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.